Recruiting
Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC
About this study
To investigate genomic architecture, cancer evolution and their relationship with clinical outcomes in EGFR-mutant NSCLC.
- Condition
- Non-small Cell Lung Cancer
- Sponsor
- Sun Yat-sen University
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 8
- Minimum age: 18 years
- Study condition: Non-small Cell Lung Cancer
- Aged 18 years or older
- Histologically or cytologically confirmed non-small-cell lung cancer
- ECOG PS=0-2
- EGFR mutations confirmed by tissue or peripheral blood
- Can provide tumor tissue samples (fresh or archived)
- The subject should have good compliance, who would participate in the research voluntarily, and sign the informed consent
Exclusion 4
- History of other malignancies within 5 years (excluding basal cell carcinoma of the skin or other carcinoma in situ that has been resected).
- Unable to provide sufficient tumor tissue for analysis.
- Subjects with active, unstable systemic diseases, such as active infection, uncontrolled hypertension, heart failure (NYHA class \>= II), unstable angina pectoris, acute coronary syndrome, severe arrythmia, severe liver, kidney or metabolic diseases, HIV infection.
- Subjects who are deemed unable to comply with the study requirements or complete the study.
Where
1 site, 1 recruiting
Sun Yat-sen University Cancer Center
Guanzhou, China
Contact
-
Shen Zhao, MD.
86 20 87343366 zhaoshen@sysucc.org.cn
Potential match only. Final eligibility is determined by the study team.